GlassScriptPhysician profile
Michael Sulewski
NPI 1063808996
$1,110.18
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $931 · 2020: $59.19 · 2022: $120.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $514.81 | 2019 | |
| Glaukos Corporation | $218.26 | 2019-2020 | |
| Carl Zeiss Meditec, INC. | $120.00 | 2022 | |
| Dompe US, INC. | $105.00 | 2019 | |
| Eyepoint US, INC. | $46.96 | 2019 | |
| Sun Pharmaceutical Industries INC. | $43.78 | 2019 | |
| Alcon Vision LLC | $24.49 | 2020 | |
| Biotissue Holdings INC. | $22.64 | 2020 | |
| Ocular Therapeutix, INC. | $14.24 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Sulewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.